Antihypertensive drugs: proposed sites and mechanisms of action.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D002415:Cats; D003000:Clonidine / Q000494:pharmacology; D003714:Denervation; D004285:Dogs; D006339:Heart Rate / Q000187:drug effects; D008784:Methysergide / Q000494:pharmacology; D013948:Moxisylyte / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011224:Prazosin / Q000494:pharmacology; D014498:Uracil / Q000031:analogs & derivatives / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D010879:Piperazines; D014498:Uracil; C015568:urapidil; D003000:Clonidine; D013948:Moxisylyte; D011224:Prazosin; D008784:Methysergide; D010646:Phentolamine